General information about company

Scrip code506854
NSE Symbol
MSEI Symbol
ISIN*INE639B01015
Name of companyTANFAC INDUSTRIES LIMITED
Type of company
Class of securityEquity
Date of start of financial year01-04-2022
Date of end of financial year31-03-2023
Date of board meeting when results were approved21-04-2023
Date on which prior intimation of the meeting for considering financial results was informed to the exchange12-04-2023
Description of presentation currencyINR
Level of rounding used in financial resultsLakhs
Reporting QuarterYearly
Nature of report standalone or consolidatedStandalone
Whether results are audited or unauditedAudited
Segment ReportingSingle segment
Description of single segmentCHEMICAL
Start date and time of board meeting21-04-2023 16:00
End date and time of board meeting21-04-2023 17:30
Whether cash flow statement is applicable on companyYes
Type of cash flow statementCash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualificationDeclaration of unmodified opinion



Financial Results – Ind-AS

Particulars3 months/ 6 months ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
ADate of start of reporting period01-01-202301-04-2022
BDate of end of reporting period31-03-202331-03-2023
CWhether results are audited or unauditedAuditedAudited
DNature of report standalone or consolidatedStandaloneStandalone
Part IBlue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1Income
Revenue from operations11552.96537494.811
Other income629.415792.175
Total income12182.3838286.986
2Expenses
(a)Cost of materials consumed6797.00922880.952
(b)Purchases of stock-in-trade00
(c)Changes in inventories of finished goods, work-in-progress and stock-in-trade45.445-206.075
(d)Employee benefit expense 451.4471629.842
(e)Finance costs30.84388.428
(f)Depreciation, depletion and amortisation expense171.431633.271
(f)Other Expenses
1Power & Fuel436.7921603.945
2Other Expenses1239.4454110.381
10
Total other expenses1676.2375714.326
Total expenses9172.41230740.744

Financial Results – Ind-AS

Particulars3 months/ 6 months ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
ADate of start of reporting period01-01-202301-04-2022
BDate of end of reporting period31-03-202331-03-2023
CWhether results are audited or unauditedAuditedAudited
DNature of report standalone or consolidatedStandaloneStandalone
Part IBlue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
3Total profit before exceptional items and tax3009.9687546.242
4Exceptional items 00
5Total profit before tax3009.9687546.242
7Tax expense
8Current tax769.241935.81
9Deferred tax2.91-2.546
10Total tax expenses772.151933.264
11Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement00
14Net Profit Loss for the period from continuing operations2237.8185612.978
15Profit (loss) from discontinued operations before tax00
16Tax expense of discontinued operations00
17Net profit (loss) from discontinued operation after tax00
19Share of profit (loss) of associates and joint ventures accounted for using equity method00
21Total profit (loss) for period2237.8185612.978
22Other comprehensive income net of taxes1.72-6.2

Financial Results – Ind-AS

Particulars3 months/ 6 months ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
ADate of start of reporting period01-01-202301-04-2022
BDate of end of reporting period31-03-202331-03-2023
CWhether results are audited or unauditedAuditedAudited
DNature of report standalone or consolidatedStandaloneStandalone
Part IBlue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
23Total Comprehensive Income for the period2239.5385606.778
24Total profit or loss, attributable to
Profit or loss, attributable to owners of parent
Total profit or loss, attributable to non-controlling interests
25Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent00
Total comprehensive income for the period attributable to owners of parent non-controlling interests00
26Details of equity share capital
Paid-up equity share capital997.5997.5
Face value of equity share capital1010
27Details of debt securities
28Reserves excluding revaluation reserve0
29Earnings per share
iEarnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations22.4356.27
Diluted earnings (loss) per share from continuing operations22.4356.27
iiEarnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations00
Diluted earnings (loss) per share from discontinued operations00
iiEarnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations22.4356.27
Diluted earnings (loss) per share from continuing and discontinued operations22.4356.27
30Debt equity ratio
31Debt service coverage ratio
32Interest service coverage ratio
33Disclosure of notes on financial resultsTextual Information(1)

Text Block

Textual Information(1)1. The above audited financial results were reviewed by the Audit Committee and approved by the Board of Directors at its meeting held on 21st April 2023.

2.The company operates in a single segment i.e, Chemicals in India and all other activities evolve around the same. Hence, there is no reportable primary/ secondary segment in accordance with the requirements of Ind AS 108, 'Operating Segments'.

3.# Figures of the last quarter are the balancing figures between audited figures in respect of the full financial year and published year to date reviewed figures upto the 3rd quarter of the relevant financial year.

4.The Board of Directors, in their meeting held on 21st April 2023, have recommended dividend of Rs.6.50/- per equity share of face value of Rs.10/- each for the financial year 2022-23 subject to approval by members in the ensuing Annual General Meeting (Previous Year Rs.5.50/- per Equity Share).

5.The Board of Directors, at its meeting held on 10th February 2023, have accorded its approval to the Company's expansion project for doubling its existing capacity of Hydrofluoric Acid Plant at Cuddalore at an estimated cost of around Rs.100 Crores to be implemented over the period of 15 to 18 months.

6.Other Income of Rs. 629.41 Lakhs during the quarter ending March'23 includes an amount of Rs.440.90 Lakhs towards Claims admitted by a Raw Material supplier for non supply of Purchase Order quantity as per the Contract terms.
7. Figures for the previous period / year have been rearranged /reclassified wherever necessary, to correspond with current period / year presentation.



Statement of Asset and Liabilities

ParticularsCurrent year ended (dd-mm-yyyy)
Date of start of reporting period01-04-2022
Date of end of reporting period31-03-2023
Whether results are audited or unauditedAudited
Nature of report standalone or consolidatedStandalone
Assets
1 Non-current assets
Property, plant and equipment5471.04
Capital work-in-progress593.03
Investment property
Goodwill0
Other intangible assets0
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments141.93
Trade receivables, non-current
Loans, non-current0
Other non-current financial assets13.09
Total non-current financial assets155.02
Deferred tax assets (net)
Other non-current assets82.55
Total non-current assets6301.64
2Current assets
Inventories5292.9
Current financial asset
Current investments6562.37
Trade receivables, current5077.85
Cash and cash equivalents389.73
Bank balance other than cash and cash equivalents878.27
Loans, current0
Other current financial assets0.75
Total current financial assets12908.97
Current tax assets (net)68.47
Other current assets608.93
Total current assets18879.27

Statement of Asset and Liabilities

ParticularsCurrent year ended (dd-mm-yyyy)
Date of start of reporting period01-04-2022
Date of end of reporting period31-03-2023
Whether results are audited or unauditedAudited
Nature of report standalone or consolidatedStandalone
3Non-current assets classified as held for sale
4Regulatory deferral account debit balances and related deferred tax Assets
Total assets25180.91
Equity and liabilities
Equity
Equity attributable to owners of parent
Equity share capital997.5
Other equity17429.963
Total equity attributable to owners of parent18427.463
Non controlling interest
Total equity18427.463
Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current0
Trade payables, non-current
Other non-current financial liabilities
Total non-current financial liabilities0
Provisions, non-current110.38
Deferred tax liabilities (net)317.4
Deferred government grants, Non-current
Other non-current liabilities
Total non-current liabilities427.78
Current liabilities
Current financial liabilities
Borrowings, current0
Trade payables, current4639.23
Other current financial liabilities
Total current financial liabilities4639.23
Other current liabilities553.647
Provisions, current1026.941
Current tax liabilities (Net)105.849
Deferred government grants, Current
Total current liabilities6325.667
3Liabilities directly associated with assets in disposal group classified as held for sale
4Regulatory deferral account credit balances and related deferred tax liability
Total liabilities6753.447
Total equity and liabilites25180.91
Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results

Particulars3 months/ 6 month ended (dd-mm-yyyy)Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period01-01-202301-04-2022
Date of end of reporting period31-03-202331-03-2023
Whether accounts are audited or unauditedAuditedAudited
Nature of report standalone or consolidatedStandaloneStandalone
1Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3(Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments

Cash flow statement, indirect

ParticularsYear ended (dd-mm-yyyy)
ADate of start of reporting period01-04-2022
BDate of end of reporting period31-03-2023
CWhether results are audited or unauditedAudited
DNature of report standalone or consolidatedStandalone
Part IBlue color marked fields are non-mandatory.
Statement of cash flows
Cash flows from used in operating activities
Profit before tax7546.242
Adjustments for reconcile profit (loss)
Adjustments for finance costs88.428
Adjustments for decrease (increase) in inventories-1145.717
Adjustments for decrease (increase) in trade receivables, current-2524.04
Adjustments for decrease (increase) in trade receivables, non-current0
Adjustments for decrease (increase) in other current assets-186.88
Adjustments for decrease (increase) in other non-current assets0
Adjustments for other financial assets, non-current0
Adjustments for other financial assets, current0
Adjustments for other bank balances0
Adjustments for increase (decrease) in trade payables, current1725.88
Adjustments for increase (decrease) in trade payables, non-current0
Adjustments for increase (decrease) in other current liabilities0
Adjustments for increase (decrease) in other non-current liabilities0
Adjustments for depreciation and amortisation expense633.271
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss0
Adjustments for provisions, current-36.45
Adjustments for provisions, non-current0
Adjustments for other financial liabilities, current0
Adjustments for other financial liabilities, non-current0
Adjustments for unrealised foreign exchange losses gains23.49
Adjustments for dividend income0
Adjustments for interest income30.589
Adjustments for share-based payments0
Adjustments for fair value losses (gains)54.41
Adjustments for undistributed profits of associates0
Other adjustments for which cash effects are investing or financing cash flow0
Other adjustments to reconcile profit (loss)-131.413
Other adjustments for non-cash items0
Share of profit and loss from partnership firm or association of persons or limited liability partnerships0
Total adjustments for reconcile profit (loss)-1529.61
Net cash flows from (used in) operations6016.632
Dividends received0
Interest paid0
Interest received0
Income taxes paid (refund)1722.762
Other inflows (outflows) of cash0
Net cash flows from (used in) operating activities4293.87
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses0
Cash flows used in obtaining control of subsidiaries or other businesses0
Other cash receipts from sales of equity or debt instruments of other entities0
Other cash payments to acquire equity or debt instruments of other entities0
Other cash receipts from sales of interests in joint ventures0
Other cash payments to acquire interests in joint ventures0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships0
Proceeds from sales of property, plant and equipment10.05
Purchase of property, plant and equipment1491.079
Proceeds from sales of investment property11415.36
Purchase of investment property13924.32
Proceeds from sales of intangible assets0
Purchase of intangible assets0
Proceeds from sales of intangible assets under development0
Purchase of intangible assets under development0
Proceeds from sales of goodwill0
Purchase of goodwill0
Proceeds from biological assets other than bearer plants0
Purchase of biological assets other than bearer plants0
Proceeds from government grants0
Proceeds from sales of other long-term assets0
Purchase of other long-term assets0
Cash advances and loans made to other parties0
Cash receipts from repayment of advances and loans made to other parties0
Cash payments for future contracts, forward contracts, option contracts and swap contracts0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts0
Dividends received0
Interest received30.589
Income taxes paid (refund)0
Other inflows (outflows) of cash-0.01
Net cash flows from (used in) investing activities-3959.41
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries0
Payments from changes in ownership interests in subsidiaries0
Proceeds from issuing shares0
Proceeds from issuing other equity instruments0
Payments to acquire or redeem entity's shares0
Payments of other equity instruments0
Proceeds from exercise of stock options0
Proceeds from issuing debentures notes bonds etc0
Proceeds from borrowings0
Repayments of borrowings0
Payments of finance lease liabilities0
Payments of lease liabilities0
Dividends paid548.625
Interest paid88.428
Income taxes paid (refund)0
Other inflows (outflows) of cash0
Net cash flows from (used in) financing activities-637.053
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes-302.593
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents0
Net increase (decrease) in cash and cash equivalents-302.593
Cash and cash equivalents cash flow statement at beginning of period692.332
Cash and cash equivalents cash flow statement at end of period389.739